Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity

Rhythm · Phase 3 · Completed · Enrollment 15

NCT02896192

EudraCT 2016-002320-83

Y axis: Change in body weight from baseline, %

0-5-10-15-20-25-3004812162024364860Setmelanotide, week 52, -25.83%Setmelanotide

X axis: Weeks since randomization

Cited trial source. Only weeks the source states.

  • Setmelanotide: week 52 -25.83%

One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.